Needham Reiterates Buy on Merit Medical Systems, Maintains $88 Price Target
Portfolio Pulse from Benzinga Newsdesk
Needham analyst Mike Matson reiterates a Buy rating on Merit Medical Systems (MMSI) and maintains an $88 price target.

April 11, 2024 | 8:36 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Needham analyst Mike Matson reaffirmed a Buy rating on Merit Medical Systems, with an $88 price target.
The reiteration of a Buy rating and maintenance of an $88 price target by a reputable analyst could positively influence investor sentiment and potentially drive the stock price up in the short term. Analyst ratings, especially from established firms like Needham, often impact stock prices as they are considered expert opinions on the company's future performance.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100